Compounds > 1-methyltryptophan
Page last updated: 2024-08-26

1-methyltryptophan and ER-Negative PR-Negative HER2-Negative Breast Cancer

1-methyltryptophan has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bilir, C; Guney Eskiler, G1

Other Studies

1 other study(ies) available for 1-methyltryptophan and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
The efficacy of indoximod upon stimulation with pro-inflammatory cytokines in triple-negative breast cancer cells.
    Immunopharmacology and immunotoxicology, 2021, Volume: 43, Issue:5

    Topics: B7-H1 Antigen; Cell Line, Tumor; Cell Survival; Cytokines; Dose-Response Relationship, Drug; Humans; Inflammation Mediators; Interferon-gamma; Treatment Outcome; Triple Negative Breast Neoplasms; Tryptophan; Tumor Necrosis Factor-alpha

2021